Cargando…

The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis

BACKGROUND: The prevalence of mood disturbances such as anxiety and depression is greater in rheumatoid arthritis (RA) patients than in the general population. Given this association, the primary aim of this study was to assess the incremental impact of anxiety or depression on patients with RA from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peterson, Steve, Piercy, James, Blackburn, Stuart, Sullivan, Emma, Karyekar, Chetan S., Li, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816159/ https://www.ncbi.nlm.nih.gov/pubmed/31673680 http://dx.doi.org/10.1186/s41927-019-0092-5

Ejemplares similares

The prevalence and types of discordance between physician perception and objective data from standardized measures of rheumatoid arthritis disease activity in real-world clinical practice in the US
por: Wei, Wenhui, et al.
Publicado: (2019)

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
por: Waller, John, et al.
Publicado: (2017)

Correlation of Depression and Anxiety With Rheumatoid Arthritis
por: Jones Amaowei, Emilia E, et al.
Publicado: (2022)

Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis
por: James, Eddie A., et al.
Publicado: (2023)

Anxiety, Distress, and Depression in Elderly Rheumatoid Arthritis Patients
por: Karokis, Dimitrios, et al.
Publicado: (2022)

The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis
por: Cavagna, Lorenzo, et al.
Publicado: (2013)

The frequency and factors affecting anxiety and depression in patients with rheumatoid arthritis
por: Enginar, Ayşe Unal, et al.
Publicado: (2023)

High risk of depression, anxiety, and an unfavorable complex comorbidity profile is associated with SLE: a nationwide patient-level study
por: Kósa, Fruzsina, et al.
Publicado: (2022)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

The prevalence and correlation of depression and anxiety with disease activity in rheumatoid arthritis
por: Moudi, Sousan, et al.
Publicado: (2023)

Network analysis of depression and anxiety symptoms in Chinese rheumatoid arthritis patients
por: Zhang, Lijuan, et al.
Publicado: (2023)

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians
por: Sullivan, Emma, et al.
Publicado: (2020)

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)
por: Covic, Tanya, et al.
Publicado: (2012)

Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment
por: Taylor, Peter C, et al.
Publicado: (2018)

Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
por: Matcham, Faith, et al.
Publicado: (2016)

Anxiety and depression are common in rheumatoid arthritis and correlate with poor quality of life in Indian patients
por: Singh, Gurmeet, et al.
Publicado: (2021)

Anxiety and depression in rheumatoid arthritis patients: prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung’s Self-rating Anxiety Scale/Depression Scale
por: Cheng, Lu, et al.
Publicado: (2023)

Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis
por: Matcham, Faith, et al.
Publicado: (2016)

Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023)

Depression and anxiety after 2 years of follow-up in patients diagnosed with diabetes or rheumatoid arthritis
por: Gåfvels, Catharina, et al.
Publicado: (2016)

Posttraumatic Stress Disorder, Depression, Anxiety, and Persistence of Methotrexate and TNF Inhibitors in Patients with Rheumatoid Arthritis
por: Desilet, Luke W., et al.
Publicado: (2020)

Assessment of Depression, Anxiety, Stress, and quality of life in rheumatoid arthritis patients and comparison with healthy individuals
por: Khan, Aslam, et al.
Publicado: (2021)

Depression and the risk of rheumatoid arthritis
por: Vallerand, Isabelle A., et al.
Publicado: (2019)

Depression in Saudi Patients with Rheumatoid Arthritis
por: Alharbi, Samar
Publicado: (2023)

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features
por: Fragoulis, George E, et al.
Publicado: (2020)

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis
por: Mease, Philip J, et al.
Publicado: (2021)

Effect of solution-focused approach on anxiety and depression in patients with rheumatoid arthritis: A quasi-experimental study
por: Zhang, Chunli, et al.
Publicado: (2022)

Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control
por: Furst, Daniel E., et al.
Publicado: (2017)

Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
por: Jiang, Nan, et al.
Publicado: (2022)

Factors of depression among patients with rheumatoid arthritis
por: Kwiatkowska, Brygida, et al.
Publicado: (2018)

Moderating role of self-efficacy on the associations of social support with depressive and anxiety symptoms in Chinese patients with rheumatoid arthritis
por: Liu, Li, et al.
Publicado: (2017)

Association between Proinflammatory Cytokines and Anxiety and Depression Symptoms in Rheumatoid Arthritis Patients: A Cross-sectional Study
por: Parlindungan, Faisal, et al.
Publicado: (2023)

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
por: Emery, Paul, et al.
Publicado: (2015)

Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
por: Neutel, Joel M., et al.
Publicado: (2013)

Depression Risk in Patients with Rheumatoid Arthritis in the United Kingdom
por: Jacob, Louis, et al.
Publicado: (2017)

Are diet and exercise associated with depression in rheumatoid arthritis patients?
por: Husivargova, A, et al.
Publicado: (2023)

The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis – a pooled analysis of five randomised controlled trials
por: Manning-Bennett, Arkady T., et al.
Publicado: (2022)

The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic
por: Sargın, Gökhan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gb16c8q330ii2kv8iun6uk32qf